ML-192
ML-192
ML-192 is a chemical compound that has garnered interest in the field of medical research due to its potential therapeutic applications. This article provides a comprehensive overview of ML-192, including its chemical properties, mechanism of action, and potential uses in medicine.
Chemical Properties[edit | edit source]
ML-192 is a small molecule inhibitor with the chemical formula C₁₉H₁₈N₂O₃. It is characterized by its aromatic structure and the presence of functional groups that contribute to its biological activity. The compound is synthesized through a series of organic reactions, which involve the formation of key intermediates that are subsequently modified to yield the final product.
Mechanism of Action[edit | edit source]
ML-192 functions primarily as an inhibitor of the enzyme PARP1 (Poly (ADP-ribose) polymerase 1). PARP1 is involved in the repair of single-strand DNA breaks through the base excision repair pathway. By inhibiting PARP1, ML-192 prevents the repair of DNA damage, leading to the accumulation of DNA breaks and ultimately cell death. This mechanism is particularly effective in cancer cells that rely heavily on PARP1 for survival.
Therapeutic Applications[edit | edit source]
ML-192 has shown promise in preclinical studies as a potential treatment for various types of cancer, including breast cancer, ovarian cancer, and prostate cancer. Its ability to selectively target cancer cells while sparing normal cells makes it an attractive candidate for further development. Additionally, ML-192 is being investigated for its role in enhancing the efficacy of existing chemotherapeutic agents by sensitizing cancer cells to DNA-damaging treatments.
Research and Development[edit | edit source]
Ongoing research is focused on optimizing the pharmacokinetic properties of ML-192 to improve its bioavailability and reduce potential side effects. Clinical trials are being designed to evaluate the safety and efficacy of ML-192 in human subjects, with the aim of advancing it through the drug development pipeline.
Also see[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
